We thus analyzed the relationships between clinical characteristics of patients with HBV-HCC and expression of total MTA1 and MTA1dE4. We also explored the clinical impact of MTA1 and one of its major spliced variants, MTA1dE4, on postoperative recurrence in patients with HBV-HCC in Taiwan through a 4-year retrospective cohort study [32]. Here, MTA1 is linked to hepatocellular carcinoma.